We are live on
!
Find out more
ML
McAdam LLC Portfolio holdings
AUM
$2.59B
1-Year Est. Return
21.24%
This Fund
S&P 500
This Quarter
Est. Return
+6.07%
1 Year Est. Return
+21.24%
3 Year Est. Return
+57.44%
5 Year Est. Return
+51.44%
10 Year Est. Return
–
AUM
$881M
AUM Growth
+$172M
(+24%)
Cap. Flow
+$118M
Cap. Flow
% of AUM
13.37%
Top 10 Holdings %
Top 10 Hldgs %
62.46%
Holding
180
New
19
Increased
101
Reduced
39
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large- Cap ETF
SCHX
|
+$14.5M |
| 2 |
Schwab International Equity ETF
SCHF
|
+$11.8M |
| 3 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$11.6M |
| 4 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$11.3M |
| 5 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$7.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
|
+$616K |
| 2 |
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
|
+$576K |
| 3 |
FSKR
FS KKR Capital Corp. II
FSKR
|
+$565K |
| 4 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$446K |
| 5 |
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
|
+$355K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.65% |
| 2 | Technology | 1.57% |
| 3 | Healthcare | 1.1% |
| 4 | Consumer Discretionary | 0.76% |
| 5 | Financials | 0.65% |
Similar funds
CF
PA
VWM
MFAM
MG
PI
BCF
FHC
McAdam LLC's Q2 2021 Portfolio in Review
As of Q2 2021, McAdam LLC held 180 positions worth $881M, up 24% from $709M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
McAdam LLC deployed $118M of net new capital in Q2 2021, opening 19 new positions and adding to 101 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 3,345 shares worth $1.95M.
By sector, the portfolio is most concentrated in Miscellaneous at 95% of assets, down from 95% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 400 Mid Cap Growth ETF, an estimated $616K trimmed.
- McAdam LLC's largest Q2 2021 buy was Regeneron Pharmaceuticals: 3,345 shares worth $1.95M.
- McAdam LLC added most to Schwab US Large- Cap ETF in Q2 2021, an estimated $14.5M increase.
- McAdam LLC's biggest Q2 2021 reduction was State Street SPDR S&P 400 Mid Cap Growth ETF, cutting an estimated $616K.
- McAdam LLC fully exited FS KKR Capital Corp. II in Q2 2021, selling an estimated $565K.
- McAdam LLC's ten largest holdings make up 62% of its $881M portfolio in Q2 2021.
- McAdam LLC opened 19 new positions and closed 3 in Q2 2021.
- McAdam LLC's portfolio value rose 24% quarter-over-quarter to $881M.
Based on McAdam LLC's 13F filing for Q2 2021, filed 2 Aug 2021.